Lu L - Search Results

1

Imaging-based surrogate classification for risk stratification of hepatocellular carcinoma with microvascular invasion to adjuvant hepatic arterial infusion chemotherapy: a multicenter retrospective study.

Ma L, Zhang C, Wen Y, Xing K, Li S, Geng Z, Liao S, Yuan S, Li X, Zhong C, Hou J, Zhang J, Gao M, Xu B, Guo R, Wei W, Xie C, Lu L. Ma L, et al. Among authors: lu l. Int J Surg. 2024 Jul 24. doi: 10.1097/JS9.0000000000001903. Online ahead of print. Int J Surg. 2024. PMID: 39051653

2

Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.

Lu LH, Zhang YF, Wei W, Shi M, Guo RP. Lu LH, et al. J Gastrointest Surg. 2017 Dec;21(12):2025-2032. doi: 10.1007/s11605-017-3528-5. Epub 2017 Aug 24. J Gastrointest Surg. 2017. PMID: 28840443

3

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent.

Kan A, Le Y, Zhang YF, Duan FT, Zhong XP, Lu LH, Ling YH, Guo RP. Kan A, et al. J Cancer. 2018 Jun 14;9(14):2415-2427. doi: 10.7150/jca.24406. eCollection 2018. J Cancer. 2018. PMID: 30026838 Free PMC article.

4

Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.

Lu LH, Zhang YF, Mu-Yan C, Kan A, Zhong XP, Mei J, Ling YH, Li SH, Shi M, Wei W, Guo RP. Lu LH, et al. Dig Liver Dis. 2019 Oct;51(10):1430-1437. doi: 10.1016/j.dld.2019.04.006. Epub 2019 May 1. Dig Liver Dis. 2019. PMID: 31054962 Free article.

5

NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.

Zhong XP, Kan A, Ling YH, Lu LH, Mei J, Wei W, Li SH, Guo RP. Zhong XP, et al. Cell Death Dis. 2019 May 8;10(5):369. doi: 10.1038/s41419-019-1603-4. Cell Death Dis. 2019. PMID: 31068575 Free PMC article.

6

Anatomical versus Non-anatomical Resection for Hepatocellular Carcinoma with Microscope Vascular Invasion: A Propensity Score Matching Analysis.

Zhong XP, Zhang YF, Mei J, Li SH, Kan A, Lu LH, Chen MS, Wei W, Guo RP. Zhong XP, et al. J Cancer. 2019 Jul 5;10(17):3950-3957. doi: 10.7150/jca.32592. eCollection 2019. J Cancer. 2019. PMID: 31417639 Free PMC article.

7

Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases.

Li S, Wang Q, Mei J, Wang J, Zhong XP, Ling Y, Guo Z, Lu LH, Wei W, Guo R. Li S, et al. J Cancer. 2019 Aug 27;10(20):5007-5014. doi: 10.7150/jca.35355. eCollection 2019. J Cancer. 2019. PMID: 31598173 Free PMC article.

8

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.

Mei J, Li SH, Wang QX, Zhong XP, Lu LH, Kan A, Wei W, Guo RP. Mei J, et al. Cancer Med. 2020 Jan;9(1):62-76. doi: 10.1002/cam4.2671. Epub 2019 Nov 8. Cancer Med. 2020. PMID: 31701652 Free PMC article.

9

Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma.

Huang X, He C, Lin G, Lu L, Xing K, Hua X, Sun S, Mao Y, Song Y, Wang J, Li S. Huang X, et al. Among authors: lu l. Biochem Biophys Res Commun. 2020 Apr 16;524(4):1064-1071. doi: 10.1016/j.bbrc.2020.02.042. Epub 2020 Feb 15. Biochem Biophys Res Commun. 2020. PMID: 32070494 Free article.

10

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation.

Lu LH, Mei J, Kan A, Ling YH, Li SH, Wei W, Chen MS, Zhang YF, Guo RP. Lu LH, et al. Cancer Med. 2020 May;9(9):2997-3005. doi: 10.1002/cam4.2951. Epub 2020 Feb 28. Cancer Med. 2020. PMID: 32108433 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,940 results

Search Page

Filters